# Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction

Study · id `cardio:ct-nct01372930` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01372930](<https://clinicaltrials.gov/study/NCT01372930>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01372930

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT01372930. Randomized; no masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2014-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT01372930, source copy `cardio:ctgov-nct01372930-2011-06-14`, retrieved 2026-10-26)
- Start date: 2010-04 (registry gives no type) (ClinicalTrials.gov record NCT01372930, source copy `cardio:ctgov-nct01372930-2011-06-14`, retrieved 2026-10-26)
- Primary completion: 2014-07 (anticipated) (ClinicalTrials.gov record NCT01372930, source copy `cardio:ctgov-nct01372930-2011-06-14`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: China (ClinicalTrials.gov record NCT01372930, source copy `cardio:ctgov-nct01372930-2011-06-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01372930-2011-06-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction
- Condition: Myocardial Infarction
- Intervention (Drug): Etanercept
- Intervention (Drug): saline
- Lead sponsor: Xijing Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Xijing Hospital (`cardio:org-xijing-hospital`)

## Provenance

Content hash: 48fd45cf030c2f53b7358957e035f1e0b4bdb4cba96fedef9cdb70799336534c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
